Abstract
During the last decade effects of nutrition on the brain have been discovered that had previously been unsuspected. The administration of dietary components can predictably cause profound changes in the function of neurons, resulting in alterations in the brain output we call behavior. This is a novel idea, as in the past clinicians believed that meal composition did not have an effect on brain function. The brain was thought of as a protected organ, receiving preferential treatment with regard to nutrient supply. In this chapter I shall present evidence that this isolation of the brain is not the case, with respect to three neurotransmitters and their dietary precursors. Animal studies will be presented, establishing the foundation on which clinicians base new therapies for neurologic diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Cohen E, Wurtman R: Brain acetylcholine synthesis: control by dietary choline. Science 191: 561–562, 1976.
Fernstrom J, Wurtman R: Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173: 149–152, 1971.
Gibson C, Wurtman R: Physiological control of brain norepinephrine synthesis by plasma tyrosine concentration. Life Sci 22: 1399–1406, 1978.
Wurtman J: Sources of choline and lecithin in the diet, in Barbeau A, Growdon J, Wurtman R (eds): Choline and Lecithin in Brain Disorders. New York, Raven Press, 1979, pp 73–82.
Wurtman R, Hirsch M, Growdon J: Lecithin consumption raises serum free choline levels. Lancet 2: 68–69, 1977.
Zeisel S, Growdon J, Wurtman R, et al: Lecithin treatment of tardive dyskinesia: Plasma choline responses to ingested lecithin. Neurology (in press).
Pardridge W, Cornford E, Braun L, et al: Transport of choline and choline analogues through the blood brain barrier, in Barbeau A, Growdon J, Wurtman R (eds): Choline and Lecithin in Brain Disorders. New York, Raven Press, 1979, pp 25–34.
White H, Wu J: Kinetics of choline acetyltransferases (E.C.2.3.2.6) from human and other mammalian central and peripheral nervous tissues. J Neurochem 20: 297–307, 1973.
Cohen E, Wurtman R: Brain acetylcholine: increase after systemic choline administration. Life Sci 16: 1095–1102, 1975.
Hirsch M, Growdon J, Wurtman R: Increase in hippocampal acetylcholine following choline administration. Brain Res 332: 383–385, 1977.
Ulus I, Hirsch M, Wurtman R: Trans-synaptic induction of adrenomedullary tyrosine hydroxylase activity by choline. Proc Natl Acad Sci USA 74: 798–800, 1977.
Ulus I, Wurtman R: Choline administration: activation of tryosine hydroxylase in dopaminergic neurons of rats. Science 194: 1060–1061, 1976.
Haubrich D, Gerber N, Pfleuger A: Choline availability and the synthesis of acetylcholine, in Barbeau A, Growdon R, Wurtman R (eds): Choline and Lecithin in Brain Disorders. New York, Raven Press, 1979, pp 57–72.
Bierkamper G, Goldberg A: Effect of choline on the release of acetylcholine from the neuromuscular junction, in Barbeau A, Growdon J, Wurtman R (eds): Choline and Lecithin in Brain Disorders. New York, Raven Press, 1979, pp 243–252.
Davis K, Berger P, Hollister L: Choline for tardive dyskinesia. N Engl J Med 293: 152, 1975.
American College of Neuro-Psychopharmacology-FDA Task Force. Neurologic syndromes associated with antipsychotic drug use. N Engl J Med 289: 20–23, 1973.
Jus A, Pineau R, Lachance R, et al: Epidemiology of tardive dyskinesia. Dis Nery Syst 37: 210–214, 1976.
Baldessarini R: The pathophysiological basis of tardive dyskinesia. Psychopharmacol Bull 14: 79–81, 1978.
Growdon J, Hirsch M, Wurtman R, et al: Oral choline administration to patients with tardive dyskinesia. N Engl J Med 297: 524–527, 1977.
Growdon J, Gelenberg A, Doller J, et al: Lecithin can suppress tardive dyskinesia. N Engl J Med 298: 1029–1030, 1978.
Zeisel S, Gelenberg A, Growdon J, et al: Use of choline and lecithin in the treatment of tardive dyskinesia. Adv Neuropharmacol (in press).
Etienne P, Gauthier S, Dastoor D, et al: Alzheimer’s disease: clinical effects of lecithin treatment, in Barbeau A, Growdon J, Wurtman R (eds): Choline and Lecithin in Brain Disorders. New York, Raven Press, 1979, pp 389–398.
Christie J, Blackburn I, Glen A, et al: Effects of choline and lecithin on CSF choline levels and on cognitive function in patients with presenile dementia of the Alzheimer type, in Barbeau A, Growdon J, Wurtman R (eds): Choline and Lecithin in Brain Disorders. New York, Raven Press, 1979, pp 377–388.
Barbeau A: Lecithin in movement disorders, in Barbeau A, Growdon J, Wurtman R (eds): Choline and Lecit hin in Brain Disorders. New York, Raven Press, 1979, pp 263–272.
Zeisel S, Epstein M, Wurtman R: Elevated choline concentration in neonatal plasma. Life Sci 26: 1827–1831, 1980.
Hartman E: L-tryptophan: effects on sleep. Monogr Neural Sci 3: 26–32, 1976.
Pardridge W: Regulation of amino acid availability to brain, in Wurtman R, Wurtman J (eds): Nutrition and the Brain, vol 1. New York, Raven Press, 1977, pp 141–204.
Fernstrom J, Wurtman R: Brain serotonin content: increase following ingestion of a carbohydrate diet. Science 174: 1023–1025, 1971.
Fernstrom J, Larin F, Wurtman R: Correlations between brain tryptophan and plasma neutral amino acids following food consumption in rats. Life Sci 13: 517–524, 1973.
Fernstrom J, Wurtman R: Elevation of plasma tryptophan by insulin in the rat. Metabolism 21: 337–342, 1972.
Scally M, Wurtman R: Brain tyrosine levels control striatal dopamine synthesis in haloperidol treated rats. J Neural Transm 41: 1–6, 1977.
Fernstrom J, Arnold M, Wurtman R, et al: Diurnal variations in normal and cirrhotic subjects: effect of protein consumption. J Neur Transm 14 (suppl): 133–142, 1978.
Wurtman R, Larin F, Mostafapour S, et al: Brain catechol synthesis: control by brain tyrosine concentration. Science 185: 183–184, 1974.
Wyatt R, Engelman K, Kupfer D, et al: Effects of L-tryptophan (a natural sedative) on human sleep. Lancet 2: 842–846, 1970.
Oswald I, Ashcroft G, Berger R, et al: Experiments in the chemistry of normal sleep. Br J Psychiatry 112: 391–399, 1966.
De Lean J, Richardson J, Hornykiewicz O: Beneficial effects of serotonin precursors in postanoxic action myoclonus. Neurology 26: 863–868, 1976.
Sved A, Fernstrom J, Wurtman R: Tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously hypertensive rats. Proc Natl Acad Sci USA 76: 3511–3514, 1979.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 John Wright · PSG Inc
About this chapter
Cite this chapter
Zeisel, S.H. (1982). The Effects of Dietary Components on Brain Function. In: Vitale, J.J., Broitman, S.A. (eds) Advances in Human Clinical Nutrition. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8290-1_18
Download citation
DOI: https://doi.org/10.1007/978-94-009-8290-1_18
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8292-5
Online ISBN: 978-94-009-8290-1
eBook Packages: Springer Book Archive